Virtual cGMPs and GLPs Course 2024: Quality Control Laboratory Compliance - Pre-approved by RAPS as Eligible for up to 10 Credits Towards a Participant's RAC Recertification
January 18, 2024 07:48 ET
|
Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Quality Control Laboratory Compliance - cGMPs and GLPs Course" training has been added to ResearchAndMarkets.com's offering. The pharmaceutical...
2 Day Virtual FDA Inspection Course: How to Prepare for, Host and Follow up to a Regulatory Inspection (12.0 RAC CREDITS)
January 18, 2024 07:28 ET
|
Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "FDA Inspection" training has been added to ResearchAndMarkets.com's offering. The course will go through what typically goes on during an FDA...
Fundamentals of GMPs (Good Manufacturing Practices) for Pharmaceuticals, Medical Devices, and Biologics Webinar
January 17, 2024 13:43 ET
|
Research and Markets
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "Fundamentals of GMPs" webinar has been added to ResearchAndMarkets.com's offering. What are Good Manufacturing Practices? They are a set of...
2 Day Online Pharmaceutical Industry GMP Training Course: Elevating Quality Control Laboratory Standards
January 17, 2024 10:28 ET
|
Research and Markets
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "Basic GMP Training For Quality Control Laboratory Courses" report has been added to ResearchAndMarkets.com's offering. In an effort to advance the...
Optimi Health and Sunshine Earth Labs Ltd. Forge Strategic Supply Agreement
December 07, 2023 07:30 ET
|
Optimi Health Corp.
Optimi Health and Sunshine Earth Labs Ltd. Forge Strategic Supply Agreement
Optimi Health Achieves Genetics Milestone and Completes Psilocybin Extract Validation and Stability Testing
November 28, 2023 07:42 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading end-to-end drug researcher and formulator licensed by Health...
PharmAla Completes Historic First Shipment of MDMA and Psilocybin to Cortexa
November 07, 2023 08:55 ET
|
PharmAla Biotech
PharmAla completes the historic first shipment of MDMA and Psilocybin to its Australian Joint Venture, Cortexa, for use in commercial patient treatments
Optimi Health Announces Third and Final Tranche of CAD $1,000,000 Secured for Debt Financing
November 02, 2023 07:30 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi Health” or the “Company”), a Canadian drug research and formulation...
Addressing the $250 Billion Excess Inventory Issue with New Course on Supplier Management
October 25, 2023 06:48 ET
|
Research and Markets
Dublin, Oct. 25, 2023 (GLOBE NEWSWIRE) -- In the wake of a 2023 Kearney study highlighting the stark reality of a $250+ billion problem of excess inventory in the U.S., brought sharply into focus by...
Mastering cGMP Compliance: A Comprehensive Seminar on Good Manufacturing Practices and FDA Inspections (December 11-13, 2023)
October 18, 2023 08:33 ET
|
Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Annual GMP Master Class 2023" training has been added to ResearchAndMarkets.com's offering. cGMPs or Current Good Manufacturing Practices is a...